| 000 | 01661 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513030605.0 | ||
| 264 | 0 | _c19940127 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0167-0115 | ||
| 024 | 7 |
_a10.1016/0167-0115(93)90348-c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, P D | |
| 245 | 0 | 0 |
_aInsulin-like growth factor (IGF) suppression of IGFBP-1 production: evidence for mediation by the type I IGF receptor. _h[electronic resource] |
| 260 |
_bRegulatory peptides _cOct 1993 |
||
| 300 |
_a199-206 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aCarcinoma, Hepatocellular |
| 650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin-Like Growth Factor Binding Protein 1 |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor II _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLiver Neoplasms |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aSuwanichkul, A | |
| 700 | 1 | _aDePaolis, L A | |
| 700 | 1 | _aSnuggs, M B | |
| 700 | 1 | _aMorris, S L | |
| 700 | 1 | _aPowell, D R | |
| 773 | 0 |
_tRegulatory peptides _gvol. 48 _gno. 1-2 _gp. 199-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-0115(93)90348-c _zAvailable from publisher's website |
| 999 |
_c7504934 _d7504934 |
||